Company Filing History:

4 out of 126

Novartis Finance Corporation

patents

4 out of 6,850

Ciba-geigy Corporation

Years Active: 1995-2000

Loading Chart...

11 patents (USPTO):Sort by Forward CitationsExplore Patents

1. 6166004 - Combinations of HIV protease inhibitors with reverse transcriptase (2000-12-26),

2. 6110946 - Antivirally active heterocyclic azahexane derivatives (2000-08-29),

3. 5935976 - Antiviral ethers of aspartate protease substrate isosteres (1999-08-10),

4. 5912352 - Intermediates for the preparation of peptide analogues (1999-06-15),

5. 5849911 - Antivirally active heterocyclic azahexane derivatives (1998-12-15),

6. 5807891 - Antiviral ethers of aspartate protease substrate isosteres (1998-09-15),

7. 5753652 - Antiretroviral hydrazine derivatives (1998-05-19),

8. 5670497 - Cyclic hydrazine compounds (1997-09-23),

9. 5663200 - Antiviral ethers of aspartate protease substrate isosteres (1997-09-02),

10. 5643878 - 5-amino-4-hydroxyhexanoic acid derivatives (1997-07-01),

11. 5409927 - Morpholin- and thiomorpholin-4-ylamides (1995-04-25),

Title: The Innovative Mind of Alexander Fassler

Introduction

Alexander Fassler is a notable inventor based in Oberwil, Switzerland. With an impressive portfolio of eleven patents, he has made significant contributions to the field of pharmaceuticals, particularly in the area of antiviral treatments. His work continues to influence modern medicine.

Latest Patents

Fassler's latest patents demonstrate his commitment to advancing antiviral therapies. One of his notable inventions involves combinations of HIV protease inhibitors with reverse transcriptase. This patent describes compounds formulated with specific structures that hold therapeutic potential against HIV. Another significant invention is related to antivirally active heterocyclic azahexane derivatives, again detailing particular compounds aimed at combating viral infections. Both patents highlight Fassler's innovative approach to developing effective medical solutions.

Career Highlights

Throughout his career, Alexander Fassler has worked with prominent companies, including Novartis Finance Corporation and Ciba-Geigy Corporation. His experience in these organizations provided him with a solid foundation to explore and develop his inventive ideas. Through his roles, he has continually focused on pushing the boundaries of pharmaceutical sciences.

Collaborations

Fassler has collaborated with notable colleagues such as Guido Bold and Marc Lang. These partnerships have facilitated a productive exchange of ideas, leading to groundbreaking innovations in the pharmaceutical sector. His collaborations emphasize the importance of teamwork and shared knowledge in the pursuit of advancement.

Conclusion

Alexander Fassler stands out as a creative force in the world of inventions and patents. His dedication to developing new antiviral compounds is a testament to his innovative spirit. As he continues to work on impactful projects, the legacy of his contributions to medicine will undoubtedly endure.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Inventor’s Patent Attorneys refers to legal professionals with specialized expertise in representing inventors throughout the patent process. These attorneys assist inventors in navigating the complexities of patent law, including filing patent applications, conducting patent searches, and protecting intellectual property rights. They play a crucial role in helping inventors secure patents for their innovative creations.